AB Science S.A.
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III cl…
Drug Manufacturers - Specialty & Generic
FR, Paris [HQ]
Cash Flow Statements
- Primary View
- Secondary View
Currency
USD
Value Format
100 K
M
B
T
Scope
Options
Old New
Mark < 0
Mark > 0
Tools
Switch To Charts
AB.PA SRC |
---|
Cash Flow from Operating Activities |
Depreciation and Amortization |
Deferred Taxes |
Stock Based Compensation |
Change in Working Capital |
Change in Accounts Payable |
Cash Flow from Investing Activities |
Capital Expenditures |
Acquisitions (Net) |
Investments (Purchases) |
Sales/Maturities of Investments |
Other Investing Activities |
Cash Flow from Financing Activities |
Issuance of Debt |
Repayment of Debt |
Dividends Paid |
Stock-Based Compensation (Financing Activity) |
Other Financing Activities |
Net Change in Cash |
Cash at Beginning of Period |
Effect of Forex Changes on Cash |
Cash at End of Period |